Zelira Therapeutics Limited (ZLDAF)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 94.95 Thousand | 301.12 Thousand | 1.54 Million | 663.31 Thousand | - | 769.03 Thousand |
| Cost of Revenue | 328.88 Thousand | 3.51 Million | 939.05 Thousand | 228.22 Thousand | 275.05 Thousand | - |
| Gross Profit | -233.93 Thousand | -3.21 Million | 601.57 Thousand | 435.09 Thousand | -275.05 Thousand | 769.03 Thousand |
| Operating Expenses | 10.28 Thousand | 4.19 Million | 14.24 Million | 10.19 Million | 7.93 Million | 4.23 Million |
| Selling, General and Administrative Expenses | 1.33 Million | 2.59 Million | 6.07 Million | 4.49 Million | 1.97 Million | 1.25 Million |
| Research and Development Expenses | 2.81 Million | 1.33 Million | 1.39 Million | 2.08 Million | 3.69 Million | 2.32 Million |
| Other Expenses | - | -266.52 Thousand | 1.27 Million | 1.25 Million | 925.49 Thousand | 580.44 Thousand |
| Cost and Expenses | 5.5 Million | 7.71 Million | 15.18 Million | 10.42 Million | 7.93 Million | 4.23 Million |
| Operating Income | -5.93 Million | -7.41 Million | -12.35 Million | -8.5 Million | -7 Million | -4.23 Million |
| Interest Expense | 739.27 Thousand | 76.66 Thousand | 53.84 Thousand | 42.62 Thousand | 12.34 Thousand | - |
| Income Tax Expense | - | -1.14 Million | 860.82 Thousand | 1.29 Million | 937.83 Thousand | -769.03 Thousand |
| Earnings before Tax | -36.73 Million | -7.41 Million | -12.41 Million | -8.54 Million | -7.01 Million | -3.56 Million |
| Net Income | -36.56 Million | -5.57 Million | -11.94 Million | -8.54 Million | -7.01 Million | -3.56 Million |
| Earnings Per Share Basic | -3.22 | -0.55 | -1.49 | -1.29 | -1.45 | -0.83 |
| Earnings Per Share Diluted | -3.22 | -0.55 | -1.49 | -1.29 | -1.45 | -0.83 |
| Weighted Average Shares Outstanding | 11.34 Million | 10.06 Million | 8.04 Million | 6.63 Million | 4.84 Million | 4.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.34 Million | 10.06 Million | 8.04 Million | 6.63 Million | 4.84 Million | 4.31 Million |
| Gross Margin | -2.46 | -10.68 | 0.39 | 0.66 | - | 1.00 |
| EBIT Margin | -374.10 | -22.81 | -7.64 | -12.11 | - | -5.51 |
| Profit Margin | -385.13 | -18.51 | -7.75 | -12.89 | - | -4.64 |
| EBITDA | -35.52 Million | -5.64 Million | -11.77 Million | -8.03 Million | -7.5 Million | - |
| Earnings Before Tax Margin | -62.54 | -24.62 | -8.02 | -12.82 | - | -5.51 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 94.95 Thousand | 20.11 Thousand | 20.11 Thousand | 54.72 Thousand | 27.36 Thousand | 301.12 Thousand |
| Cost of Revenue | 1.48 Million | 101.44 Thousand | 101.44 Thousand | 1.15 Million | 63 Thousand | 3.51 Million |
| Gross Profit | -1.38 Million | -81.32 Thousand | -81.32 Thousand | -1.1 Million | -35.63 Thousand | -3.21 Million |
| Operating Expenses | 4.78 Million | 1.16 Million | 1.16 Million | 2.23 Million | 17.02 Million | 4.19 Million |
| Selling, General and Administrative Expenses | - | 382.71 Thousand | 382.71 Thousand | 910.37 Thousand | 799.98 Thousand | - |
| Research and Development Expenses | - | 783.28 Thousand | 783.28 Thousand | 1.24 Million | 621.81 Thousand | - |
| Other Expenses | -244.22 Thousand | -165.27 Thousand | - | -78.95 Thousand | - | -266.52 Thousand |
| Cost and Expenses | 6.26 Million | 1.26 Million | 1.26 Million | 3.39 Million | 17.08 Million | 7.71 Million |
| Operating Income | -6.17 Million | -1.24 Million | -1.24 Million | -3.33 Million | -1.61 Million | -7.41 Million |
| Interest Expense | 739.27 Thousand | 528.13 Thousand | - | 211.13 Thousand | - | 76.66 Thousand |
| Income Tax Expense | -919.73 Thousand | -919.73 Thousand | -82.12 Thousand | -187.77 Thousand | -93.88 Thousand | -1.14 Million |
| Earnings before Tax | -37.65 Million | -1.2 Million | -1.2 Million | -34.32 Million | -17.16 Million | -7.41 Million |
| Net Income | -36.56 Million | -1.21 Million | -1.21 Million | -34.13 Million | -17.06 Million | -5.57 Million |
| Earnings Per Share Basic | - | -0.11 | -0.11 | -3.01 | -1.50 | - |
| Earnings Per Share Diluted | - | -0.11 | -0.11 | -3.01 | -1.50 | - |
| Weighted Average Shares Outstanding | 11.34 Million | 11.34 Million | 11.34 Million | 11.34 Million | 11.34 Million | 10.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.34 Million | 11.34 Million | 11.34 Million | 11.34 Million | 11.34 Million | 10.06 Million |
| Gross Margin | -14.62 | -4.04 | -4.04 | -20.19 | -1.30 | -10.68 |
| EBIT Margin | - | -63.02 | -63.02 | -55.95 | -54.97 | - |
| Profit Margin | -385.13 | -60.51 | -60.51 | -623.78 | -623.76 | -18.51 |
| EBITDA | - | -1.26 Million | -1.26 Million | -3.06 Million | -1.5 Million | - |
| Earnings Before Tax Margin | -65.01 | -62.01 | -62.01 | -61.00 | -58.88 | -24.62 |
0682
ALSAU
000036
0QT0
LEIC
AACT